3D Global Biotech Inc.

NT$26.55As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6808Healthcare
Country Taiwan
PE (Fwd) •••
TSR 6Y CAGR (9.52%)
Div yield 0.38%
ROE 1.73%
Biotechnology
Beta (5Y) 0.18
PE TTM 144.4
TSR TTM (43.39%)
Mkt cap NT$2.044B
ROIC (1.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$34
29.77%
(85.87%)
Hold 0|2|9|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.47
0.49
0.47
0.51
21.17%
28.57%
10.44%
14.39%
RevenueNT$M
150.2
157.1
164.8
162.5
11.52%
13.10%
12.78%
8.57%
Peers (US$59.75M)
Cap (US$)
PE
59.76M
—
Capital
TTM
5Y
10Y
Leveragex
0.800
0.350
0.227
EBIT/Intx
5.932
2.823
2.808
Own earn%
41.44
24.46
24.75
Sh yield%
30.42
40.58
40.34
Owners
Insiders/Inst%
8.59
56.17
Short interest%
5.98
SBC / revenue%
4.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
5–11
$1 testx
0.0
Incr. ROIC%
−1